Answers are grounded in this paper and cite their sources.
Green synthesis utilizes biological entities as reducing and stabilizing agents for nanoparticle production, offering an eco-friendly alternative to conventional physicochemical methods. Plants and algae represent two of the most promising bio-factories for this purpose, yet they differ fundamentally in their biochemical machinery and resulting nanoparticle characteristics. This review systematically compares plant-mediated and algal-mediated synthesis, focusing on the biomolecules involved, the influence of reaction parameters, the resulting physicochemical properties, and the application profiles of the synthesized nanoparticles. Both routes operate on the principle of bio reduction of metal ions by secondary metabolites or enzymatic systems, followed by capping and stabilization. Plant extracts primarily rely on phytochemicals such as polyphenols, flavonoids, and terpenoids, while algae employ a combination of photosynthetic pigments, polysaccharides, and enzymatic reductases. The key differences lie in the availability and scalability of biomass, the nature of the biomolecular corona formed on the nanoparticle surface, and the resulting biocompatibility and bioactivity. Both systems yield nanoparticles with enhanced biocompatibility and often intrinsic therapeutic properties due to the biomolecular coating. Applications span antimicrobial therapy, anticancer treatment, drug delivery, environmental remediation, and agriculture. The review concludes by addressing the critical challenges of reproducibility, seasonal variability, and scale-up, which currently limit industrial translation, and proposes standardization strategies for future development.
No takes yet. Share an insight, caveat, or question.
Hamid Kooshki (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: